<DOC>
	<DOCNO>NCT01108601</DOCNO>
	<brief_summary>Cisplatin carboplatin induce ototoxicity manifest sensorineural hearing loss , tinnitus , and/or vestibular disturbance . Ototoxicity induce via damage inner ear structure reactive oxygen specie . Previous animal study demonstrate transtympanic injection Ringer 's Lactate ( RL ) provide near complete otoprotective effect cisplatin . The purpose study determine transtympanic administration Ringer 's Lactate via pressure equalise ( PE ) tube patient undergo platinum base chemotherapy treatment prevent tinnitus , vestibular dysfunction hearing loss especially high frequency . Pre- post- chemotherapy treatment audiometry measure statistically analyse significance .</brief_summary>
	<brief_title>Transtympanic Ringer 's Lactate Prevention Cisplatin Ototoxicity</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Patients age 14 Patients undergo platinum base chemotherapy Patients agree participate study Patients unable provide consent Patients head neck cancer Patients undergo radiation head neck Patients develop tympanic perforation Patients persistent otorrhea</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Ringer 's</keyword>
	<keyword>lactate</keyword>
	<keyword>cisplatin</keyword>
	<keyword>ototoxicity</keyword>
	<keyword>hearing loss</keyword>
</DOC>